![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID Cohort
|
|
|
Reported by Jules Levin
19th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, Milan, Italy Oct 23-25 2017
A. Lacey1, W. Tinago1, E. Alvarez Barco1, A.J. Macken1, G. Sheehan2, J.S. Lambert2, A.G. Cotter1,2, P.W.G. Mallon1,2
1HIV Molecular Research Group, University College Dublin School of Medicine, Dublin, Ireland
2Mater Misericordiae University Hospital, Department of Infectious Diseases, Dublin, Ireland
![AASDL1](../images/110417/110417-1/AASDL1.gif)
![AASDL2](../images/110417/110417-1/AASDL2.gif)
![AASDL3](../images/110417/110417-1/AASDL3.gif)
![AASDL4](../images/110417/110417-1/AASDL4.gif)
![AASDL5](../images/110417/110417-1/AASDL5.gif)
![AASDL6](../images/110417/110417-1/AASDL6.gif)
![AASDL7](../images/110417/110417-1/AASDL7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|